- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Digirad readies solid-state camera
Solid-state digital gamma camera developer Digirad next week will display a completed prototype of its Notebook Imager system for the first time at a Society of Nuclear Medicine meeting, according to Karen Klause, president and CEO of the San Diego
Solid-state digital gamma camera developer Digirad next week will display a completed prototype of its Notebook Imager system for the first time at a Society of Nuclear Medicine meeting, according to Karen Klause, president and CEO of the San Diego company. Digirad several months ago filed for 510(k) clearance of the system, which, if cleared, will be the first solid-state digital gamma camera on the market.
Digirad will show a wide range of clinical images collected with Notebook Imager, including bone, cardiac, liver, and thyroid scans. Notebook Imager is capable of the same range of applications as a standard gamma camera, with the exception of whole-body bone scans, which must be acquired a section at a time, due to the camera's small field-of-view. In addition, SPECT studies are conducted with patients seated in a rotating chair.
Digirad has been building a production capacity for the systems, and is also hiring a sales force to market the cameras directly in the U.S. The company is open to OEM relationships for distribution of Notebook Imager in international markets, Klause said.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
